The “Women and Weed Survey”, conducted online by CVI (Canadian Viewpoint Inc.), on behalf of Van der Pop, found women used cannabis ‘for wellness reasons versus for social experiences’, with many regular users citing their primary reason for doing so was “to manage stress or relieve anxiety, followed by to manage pain or to combat symptoms of a medical condition (27%) and to relax (17%).”
Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis.
Medtronic announces the U.S. launch of the Intellis platform for management of certain types of chronic intractable pain which can be managed on the Samsung Galaxy Tab S2 tablet interface.
A presentation at the American Academy of Pediatrics this week discusses the increase in adverse effects of opioids among hospitalized children, with withdrawal symptoms being the most common.
Conclusion of study: “Periarticular infiltration is a viable and safe alternative to femoral nerve block for the early post-operative relief of pain following TKA”
(TKA – total knee arthroplasty).
Cite this article: Bone Joint J 2017;99-B:904–11.
Cognitive Behavioral Therapy (CBT) improved functioning with reduced depression in a study of patients with chronic pain.
Helen R. Gilpin, Alexandra Keyes, Daniel R. Stahl, Riannon Greig, Lance M. McCracken. Predictors of Treatment Outcome in Contextual Cognitive and Behavioral Therapies for Chronic Pain: A Systematic Review. The Journal of Pain, 2017; DOI: 10.1016/j.jpain.2017.04.003
Study discusses “current challenges arising in this new era of synthetic opioids, including variable potency of illicit drugs due to erratic adulteration of the drug supply with synthetic opioids, potentially changing efficacy of standard naloxone formulations for overdose rescue, potentially shorter overdose response time, and reports of fentanyl exposure among people who use drugs but are opioid naïve”